Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02969174
Expanded Access Status : Approved for marketing
First Posted : November 21, 2016
Last Update Posted : November 21, 2016
Sponsor:
Information provided by (Responsible Party):
Liming Cheng, Shanghai Tongji Hospital, Tongji University School of Medicine

Brief Summary:

To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women.

To achieve prenatal accurate identification of fetal blood group genotypes,and provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).


Condition or disease Intervention/treatment
HDFN Other: zimin Lu,Guo Sa

Detailed Description:
Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

Layout table for study information
Study Type : Expanded Access
Official Title: Clinical Professor of Shanghai Tongji Hospital

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: zimin Lu,Guo Sa
    chengzhong Liu

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Weeks to 38 Weeks   (Child)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

blood samples of pregnant couples,gender/nation/region is unlimited.

Exclusion Criteria:

adipose or hemolytic samples,overdue samples,unidentified samples


No Contacts or Locations Provided

Layout table for additonal information
Responsible Party: Liming Cheng, The President of Shanghai Tongji Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine
ClinicalTrials.gov Identifier: NCT02969174    
Other Study ID Numbers: ShangjiTongjiHsxk
First Posted: November 21, 2016    Key Record Dates
Last Update Posted: November 21, 2016
Last Verified: November 2016